- Home
- NYMT vs LIMN Comparison
NYMT vs LIMN Comparison
Compare NYMT & LIMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- LIMN
- Stock Information
- Founded
- NYMT 2003
- LIMN 2018
- Country
- NYMT United States
- LIMN United States
- Employees
- NYMT N/A
- LIMN N/A
- Industry
- NYMT Real Estate Investment Trusts
- LIMN
- Sector
- NYMT Real Estate
- LIMN
- Exchange
- NYMT Nasdaq
- LIMN NYSE
- Market Cap
- NYMT 583.3M
- LIMN 623.8M
- IPO Year
- NYMT 2004
- LIMN N/A
- Fundamental
- Price
- NYMT $6.58
- LIMN $5.93
- Analyst Decision
- NYMT Strong Buy
- LIMN
- Analyst Count
- NYMT 5
- LIMN 0
- Target Price
- NYMT $7.81
- LIMN N/A
- AVG Volume (30 Days)
- NYMT 697.6K
- LIMN 991.4K
- Earning Date
- NYMT 07-30-2025
- LIMN 01-01-0001
- Dividend Yield
- NYMT 12.16%
- LIMN N/A
- EPS Growth
- NYMT N/A
- LIMN N/A
- EPS
- NYMT 0.19
- LIMN N/A
- Revenue
- NYMT $208,943,000.00
- LIMN N/A
- Revenue This Year
- NYMT $6.23
- LIMN N/A
- Revenue Next Year
- NYMT $12.09
- LIMN N/A
- P/E Ratio
- NYMT $34.27
- LIMN N/A
- Revenue Growth
- NYMT 25.40
- LIMN N/A
- 52 Week Low
- NYMT $5.02
- LIMN $4.40
- 52 Week High
- NYMT $7.27
- LIMN $33.66
- Technical
- Relative Strength Index (RSI)
- NYMT 45.20
- LIMN N/A
- Support Level
- NYMT $6.16
- LIMN N/A
- Resistance Level
- NYMT $6.94
- LIMN N/A
- Average True Range (ATR)
- NYMT 0.19
- LIMN 0.00
- MACD
- NYMT -0.04
- LIMN 0.00
- Stochastic Oscillator
- NYMT 46.15
- LIMN 0.00
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.
About LIMN LIMINATUS PHARMA INC
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.